| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |